Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide

Open access

Abstract

Thalidomide and its derivatives exert not only therapeutic effects as immunomodulatory drugs (IMiDs) but also adverse effects such as teratogenicity, which are due in part to different C2H2 zinc-finger (ZF) transcription factors, IKZF1 (or IKZF3) and SALL4, respectively. Here, we report the structural bases for the SALL4-specific proteasomal degradation induced by 5-hydroxythalidomide, a primary thalidomide metabolite generated by the enzymatic activity of cytochrome P450 isozymes, through the interaction with cereblon (CRBN). The crystal structure of the metabolite-mediated human SALL4-CRBN complex and mutagenesis studies elucidate the complex formation enhanced by the interaction between CRBN and an additional hydroxy group of ( S )-5-hydroxythalidomide and the variation in the second residue of β-hairpin structure that underlies the C2H2 ZF-type neo-morphic substrate (neosubstrate) selectivity of 5-hydroxythalidomide. These findings deepen our understanding of the pharmaceutical action of IMiDs and provide structural evidence that the glue-type E3 ligase modulators cause altered neosubstrate specificities through their metabolism.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41467-020-18488-4

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 The formation of the SALL4 and CRBN complex as mediated by (S)-5HT or (S)-thalidomide (Thal). a Schematic diagram of the AS-based interaction assay. b Dose-dependent formation of the SALL4–CRBN complex, as determined by the titration of racemate or each enantiomer of 5HT (upper) or Thal (lower) in the AS-based assay. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± standard deviation (SD) (n = 3 independent experiments). c Crystal structures of the ternary complex of CRBN TBD (blue) and SALL4 ZF2 (salmon) mediated by (S)-5HT (left) or (S)-Thal (right), which are shown by yellow sticks. Two zinc ions (Zn2+) are represented by the gray spheres in each complex. Secondary structural elements of CRBN TBD and SALL4 ZF2 are labeled in the (S)-5HT-mediated complex. d The structures of (S)-5HT (left) and (S)-Thal (right) in the SALL4–CRBN complex. The Fo‒Fc omit map is shown by a mesh diagram at a contour level of 4.0.
Fig. 1 The formation of the SALL4 and CRBN complex as mediated by (S)-5HT or (S)-thalidomide (Thal). a Schematic diagram of the AS-based interaction assay. b Dose-dependent formation of the SALL4–CRBN complex, as determined by the titration of racemate or each enantiomer of 5HT (upper) or Thal (lower) in the AS-based assay. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± standard deviation (SD) (n = 3 independent experiments). c Crystal structures of the ternary complex of CRBN TBD (blue) and SALL4 ZF2 (salmon) mediated by (S)-5HT (left) or (S)-Thal (right), which are shown by yellow sticks. Two zinc ions (Zn2+) are represented by the gray spheres in each complex. Secondary structural elements of CRBN TBD and SALL4 ZF2 are labeled in the (S)-5HT-mediated complex. d The structures of (S)-5HT (left) and (S)-Thal (right) in the SALL4–CRBN complex. The Fo‒Fc omit map is shown by a mesh diagram at a contour level of 4.0.CC BY · PubMed Central
Fig. 2 Interactions between SALL4 ZF2 and CRBN TBD. a Structural comparison among the ternary complexes mediated by (S)-5HT, (S)-thalidomide (Thal), and pomalidomide (Pom). In the upper panel, a CRBN molecule is separated into three regions, N-terminal domain (NTD, yellow-orange), TBD (blue), and the region connecting NTD and TBD (white), which provides the interface for DDB1 (pink). In the lower panel, CRBN TBD is shown by ribbon diagrams as well as SALL4 ZF2. The colored lines in the box represent color arrangement of SALL4 ZF2 and CRBN TBD in the three complex states mediated by (S)-5HT, (S)-Thal, and Pom. The structure of the SALL4 ZF2–CRBN–DDB1 complex with Pom was generated from the coordinate data deposited in the PDB under accession number 6UML39. b Hydrogen bonds formed between the β-hairpin loop of SALL4 ZF2 and residues H357 and W400 of CRBN. c Water-mediated hydrogen-bonding network between SALL4 H417 and the residues of the CRBN TBD. d Different orientations and hydrogen-bonding networks through water molecules of SALL4 R418 in complex with the CRBN TBD as mediated by (S)-5HT (left) or (S)-thalidomide (Thal) (right). The hydrogen bonds and water molecules are represented by orange dashed lines and dots labeled w, respectively. Gray spheres are zinc ions bound to CRBN TBD and SALL4 ZF2. e Sequence alignment of SALL4 ZF2 and IKZF1 ZF2. Residues conserved in C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). The residues illustrated in c, d are shaded yellow in magenta box. Numbers correspond to SALL4 ZF2.
Fig. 2 Interactions between SALL4 ZF2 and CRBN TBD. a Structural comparison among the ternary complexes mediated by (S)-5HT, (S)-thalidomide (Thal), and pomalidomide (Pom). In the upper panel, a CRBN molecule is separated into three regions, N-terminal domain (NTD, yellow-orange), TBD (blue), and the region connecting NTD and TBD (white), which provides the interface for DDB1 (pink). In the lower panel, CRBN TBD is shown by ribbon diagrams as well as SALL4 ZF2. The colored lines in the box represent color arrangement of SALL4 ZF2 and CRBN TBD in the three complex states mediated by (S)-5HT, (S)-Thal, and Pom. The structure of the SALL4 ZF2–CRBN–DDB1 complex with Pom was generated from the coordinate data deposited in the PDB under accession number 6UML39. b Hydrogen bonds formed between the β-hairpin loop of SALL4 ZF2 and residues H357 and W400 of CRBN. c Water-mediated hydrogen-bonding network between SALL4 H417 and the residues of the CRBN TBD. d Different orientations and hydrogen-bonding networks through water molecules of SALL4 R418 in complex with the CRBN TBD as mediated by (S)-5HT (left) or (S)-thalidomide (Thal) (right). The hydrogen bonds and water molecules are represented by orange dashed lines and dots labeled w, respectively. Gray spheres are zinc ions bound to CRBN TBD and SALL4 ZF2. e Sequence alignment of SALL4 ZF2 and IKZF1 ZF2. Residues conserved in C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). The residues illustrated in c, d are shaded yellow in magenta box. Numbers correspond to SALL4 ZF2.CC BY · PubMed Central
Fig. 3 Structural bases for the effective (S)-5HT mediation of the CRBN‒SALL4 interaction. a The binding mode of (S)-5HT on the interface between the CRBN TBD and SALL4 ZF2. The H353 residue forms hydrogen bonds (dashed lines) with the 5-hydroxy group of (S)-5HT through a water molecule (dot labeled w). Gray spheres are zinc ions bound to the CRBN TBD and SALL4 ZF2. b Superimposed structures of the CRBN TBD in complex with SALL4 and (S)-thalidomide (Thal, blue), neosubstrate-free state binding of (S)-Thal (wheat) and (R)-Thal (lime). (S)-Thal in the SALL4–CRBN complex is represented by yellow sticks, and the stick models of (S)- and (R)-Thal are colored the same as the coordinates in CRBN in the neosubstrate-free state. Zinc ions are shown as gray spheres. The black dashed line connects the missing chain of the neosubstrate-free CRBN TBD, which corresponds to a part of two β-strands, β3 and β4, observed in the SALL4–CRBN complex. The structures of the neosubstrate-free CRBN with (S)- and (R)-Thal were generated from the coordinates deposited in the PDB under accession numbers 5YJ0 and 5YJ137. c Enlarged views of the stick models of Thal in b. d ITC thermograms of the wild-type (WT) and H353A mutant of the CRBN TBD titrated with (S)-5HT and (S)-Thal. The values of the dissociation constant (KD) and molar binding ratio (N) were calculated with mean values ± SD (n = 3 independent experiments). e Effect of the H353A mutation in CRBN on the SALL4 interactions induced by (S)-5HT or (S)-Thal. AS signals are expressed as the relative luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). f Effect of the H353A mutation in CRBN on the (S)-5HT- or (S)-Thal-mediated proteasomal degradation of SALL4. The experiment was repeated three times independently with similar results.
Fig. 3 Structural bases for the effective (S)-5HT mediation of the CRBN‒SALL4 interaction. a The binding mode of (S)-5HT on the interface between the CRBN TBD and SALL4 ZF2. The H353 residue forms hydrogen bonds (dashed lines) with the 5-hydroxy group of (S)-5HT through a water molecule (dot labeled w). Gray spheres are zinc ions bound to the CRBN TBD and SALL4 ZF2. b Superimposed structures of the CRBN TBD in complex with SALL4 and (S)-thalidomide (Thal, blue), neosubstrate-free state binding of (S)-Thal (wheat) and (R)-Thal (lime). (S)-Thal in the SALL4–CRBN complex is represented by yellow sticks, and the stick models of (S)- and (R)-Thal are colored the same as the coordinates in CRBN in the neosubstrate-free state. Zinc ions are shown as gray spheres. The black dashed line connects the missing chain of the neosubstrate-free CRBN TBD, which corresponds to a part of two β-strands, β3 and β4, observed in the SALL4–CRBN complex. The structures of the neosubstrate-free CRBN with (S)- and (R)-Thal were generated from the coordinates deposited in the PDB under accession numbers 5YJ0 and 5YJ137. c Enlarged views of the stick models of Thal in b. d ITC thermograms of the wild-type (WT) and H353A mutant of the CRBN TBD titrated with (S)-5HT and (S)-Thal. The values of the dissociation constant (KD) and molar binding ratio (N) were calculated with mean values ± SD (n = 3 independent experiments). e Effect of the H353A mutation in CRBN on the SALL4 interactions induced by (S)-5HT or (S)-Thal. AS signals are expressed as the relative luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). f Effect of the H353A mutation in CRBN on the (S)-5HT- or (S)-Thal-mediated proteasomal degradation of SALL4. The experiment was repeated three times independently with similar results.CC BY · PubMed Central
Fig. 4 C2H2 ZF-type neosubstrate selectivity of (S)-5HT. a Distinct residues located near the 5-hydroxy group of (S)-5HT in the ZF2 of SALL4 (V411 and R418) and IKZF1 (Q146 and S153). (S)-5HT and pomalidomide are shown by yellow and cyan sticks, respectively. Gray spheres are zinc ions observed in both complex structures. The magenta dashed-line circle indicates the position of the 5-hydroxy group on the phthalimide moiety. The structure of the IKZF1–CRBN complex with pomalidomide was generated from the coordinate data deposited in the PDB under accession number 6H0F24. b Sequence alignment of SALL4 ZF2 and IKZF1 ZF2. Residues conserved in C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). The residues illustrated in a are shaded yellow in magenta boxes. Numbers on the sequences correspond to SALL4 ZF2. The residue position of β-hairpin structure is indicated on the diagram of secondary structure. c, e Effect of the residue-swap mutations in SALL4 (c) and IKZF1 (e) on the CRBN interaction induced by (S)-5HT or (S)-thalidomide (Thal). AS signals are expressed as the relative luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). d, f Effect of the residue-swap mutations in SALL4 (d) or IKZF1 (f) on the proteasomal degradation of each through their interaction with CRBN as mediated by (S)-5HT or (S)-Thal. The experiment was repeated three times independently with similar results.
Fig. 4 C2H2 ZF-type neosubstrate selectivity of (S)-5HT. a Distinct residues located near the 5-hydroxy group of (S)-5HT in the ZF2 of SALL4 (V411 and R418) and IKZF1 (Q146 and S153). (S)-5HT and pomalidomide are shown by yellow and cyan sticks, respectively. Gray spheres are zinc ions observed in both complex structures. The magenta dashed-line circle indicates the position of the 5-hydroxy group on the phthalimide moiety. The structure of the IKZF1–CRBN complex with pomalidomide was generated from the coordinate data deposited in the PDB under accession number 6H0F24. b Sequence alignment of SALL4 ZF2 and IKZF1 ZF2. Residues conserved in C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). The residues illustrated in a are shaded yellow in magenta boxes. Numbers on the sequences correspond to SALL4 ZF2. The residue position of β-hairpin structure is indicated on the diagram of secondary structure. c, e Effect of the residue-swap mutations in SALL4 (c) and IKZF1 (e) on the CRBN interaction induced by (S)-5HT or (S)-thalidomide (Thal). AS signals are expressed as the relative luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). d, f Effect of the residue-swap mutations in SALL4 (d) or IKZF1 (f) on the proteasomal degradation of each through their interaction with CRBN as mediated by (S)-5HT or (S)-Thal. The experiment was repeated three times independently with similar results.CC BY · PubMed Central
Fig. 5 CRBN-binding selectivity is affected by the V411 residue in SALL4. a Sequence alignment of SALL4 ZF2 and other C2H2 ZF domains according to the binding capacity of pomalidomide-engaged CRBN24. Residues conserved in the C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). Arrow indicates the second residue of β-hairpin structure in C2H2 ZF-type neosubstrates. Numbers correspond to SALL4 ZF2. b Chemical structures of pomalidomide (Pom) and 5-hydroxypomalidomide (5HP). c Dose-dependent interaction of CRBN with SALL4 (left) and IKZF1 (right), as observed with the titration of racemate, Pom, and 5HP in the AS-based assay. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). d Comparison of Pom- or 5HP-dependent degradation of SALL4 and IKZF1. The experiment was repeated three times independently with similar results. e The effect of V411 mutation in SALL4 on the CRBN interaction mediated by (S)-thalidomide (Thal), (S)-5HT, Pom, or 5HP. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments).
Fig. 5 CRBN-binding selectivity is affected by the V411 residue in SALL4. a Sequence alignment of SALL4 ZF2 and other C2H2 ZF domains according to the binding capacity of pomalidomide-engaged CRBN24. Residues conserved in the C2H2 ZF domains are shaded in cyan (Cys), orange (Gly), or lime (His). Arrow indicates the second residue of β-hairpin structure in C2H2 ZF-type neosubstrates. Numbers correspond to SALL4 ZF2. b Chemical structures of pomalidomide (Pom) and 5-hydroxypomalidomide (5HP). c Dose-dependent interaction of CRBN with SALL4 (left) and IKZF1 (right), as observed with the titration of racemate, Pom, and 5HP in the AS-based assay. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments). d Comparison of Pom- or 5HP-dependent degradation of SALL4 and IKZF1. The experiment was repeated three times independently with similar results. e The effect of V411 mutation in SALL4 on the CRBN interaction mediated by (S)-thalidomide (Thal), (S)-5HT, Pom, or 5HP. AS signals are expressed as the luminescence signal relative to the luminescence signal of DMSO, which is considered equal to one. Data are presented as mean values ± SD (n = 3 independent experiments).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 56 references

Cited by

See all 90

Metadata

Authors
Furihata, H., Yamanaka, S., Honda, T., Miyauchi, Y., Asano, A., Shibata, N., Tanokura, M., Sawasaki, T., & Miyakawa, T.
Affiliations
  • The University of Tokyo (JP)
  • Ehime University (JP)
  • Nagoya Institute of Technology (JP)
Corresponding author
  • Tanokura, Masaru
  • Sawasaki, Tatsuya
  • Miyakawa, Takuya
Venue
Nature Communications
Published
2020-09-14
Volume
11
Issue
1
Pages
4578-4578
ISSN
2041-1723 (ISSN-L)
OpenAlex
W3085433450
Cited by
89
References
56
Citations by year
2026: 15 · 2025: 27 · 2024: 16 · 2023: 13 · 2022: 11 · 2021: 6 · 2020: 1
FWCI
2.51
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Communications (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
MEXT | Japan Society for the Promotion of Science (JP17J0844)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Structural Biology › Enzyme Structure and Function
Keywords
immunomodulators, SALL4, cereblon, C2H2 zinc finger transcription factor, proteasomal degradation, E3 ubiquitin ligase, cytochrome P450 metabolism, drug selectivity, teratogenicity
MeSH terms
Protein Domains, Amino Acid Sequence, Humans, Immunologic Factors, Protein Binding, Stereoisomerism, Substrate Specificity, Thalidomide, Transcription Factors, Structural Homology, Protein, Ubiquitin-Protein Ligases, Adaptor Proteins, Signal Transducing, HEK293 Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. https://app.cochat.ai/papers/10.1038/s41467-020-18488-4
The paper
Furihata, H., Yamanaka, S., Honda, T., Miyauchi, Y., Asano, A., Shibata, N., Tanokura, M., Sawasaki, T., & Miyakawa, T. (2020). Structural bases of IMiD selectivity that emerges by 5-hydroxythalidomide. Nature Communications. https://doi.org/10.1038/s41467-020-18488-4

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.